Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when?

Tarih
2016
Yazar
Yarman, Sema
Selcukbiricik, Ozlem Soyluk
Tanrikulu, Seher
Dogansen, Sema Ciftci
Üst veri
Tüm öğe kaydını göster
Özet
Purpose The aim of the study was to assess the effect of dopamine agonist (DA) withdrawal, the current recurrence rate of hyperprolactinemia, and possible factors that predict recurrence in patients with prolactinoma.
Bağlantı
http://hdl.handle.net/20.500.12627/11688
https://doi.org/10.1007/s11102-016-0708-3
Koleksiyonlar